Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

Clinical trial NCT06298123 · COMPLETED

Trial details

NCT number: NCT06298123
Sponsor: Chen Xiaoping
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Adjuvant Immunotherapy Checkpoint Inhibitor

Start date: 2019-02-01
Primary completion: 2023-02-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.